Competition from biosimilars drives price reductions for biologics in the French single payer health system

6 August 2021 - France has a single payer health insurance system that has the authority to impose pharmaceutical price reductions ...

Read more →

A new incentive to encourage the prescription of biosimilars

26 April 2018 - The Directorate General of Health Care Supply and the Directorate General of Social Security published a ...

Read more →